Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for Renal Function in Mitral Valve Surgery
NCT01969071Phase 4Completed
- Sponsor
- Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi
- Start
- Jul 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in mitral valve insufficiency (MR), heart failure with reduced ejection fraction (HFrEF), sponsored by Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi. Started Jul 2009; status: completed.
02
Drugs
levosimendan
03
Conditions
mitral valve insufficiency (MR)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT01969071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969071.